The paratumoral immune cell signature reveals the potential for the implementation of immunotherapy in esophageal carcinoma patients

ConclusionThe novel association of the disease state with tumoral and paratumoral immune cell signatures suggests new possibilities for personalized immunotherapy for EC patients.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research